Serum institute hadapsar

Serum Institute of India is a biotechnology company. It produces and develops immunobiological drugs and vaccines for polio, diphtheria, tetanus, pertussis, Hib, BCG, r-hepatitis b, measles, mumps, and rubella diseases. Type Subsidiary Status Active Founded 1966 HQ Pune, IN | Website Cybersecurity rating

Serum Institute of India General Information Description Manufacturer of vaccines & immuno-biologicals based in Pune, India. The company develops specialized life-saving biologicals that include Tetanus Toxoid, Diphtheria, Measles, Mumps, Rubella, Covid-19 and Hepatitis-B vaccines using cutting-edge genetic and cell-based technologies, antisera and other medical specialties, at affordable prices and in abundance, helping treat diseases through national immunization programs. Contact Information Serum Institute of India Competitors (5) Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount Private Equity-Backed Mumbai, India 0000 00000000000 000000 0000000 Venture Capital-Backed Gurugram, India 000 00.000 0000000000 0 00.000 000000 0000000 Private Equity-Backed Hyderabad, India 0000 000.00 00000000000 000.00 000000 Formerly PE-Backed Bengaluru, India 00000 000.00 00000000 000.00 0000000 000000 Angel-Backed New Delhi, India 0000 Serum Institute of India Recent Patent Activity Publication ID Patent Title Status First Filing Date Technology (CPC) Citations EP-4145124-A1 Method for monitoring stability of polysaccharide-protein conjugate vaccines Pending 04-Sep-2021 000000000 GB-202212836-D0 Method for monitoring stability of polysaccharide-protein conjugate vaccines Pending 04-Sep-2021 0000000000 US-20230070714-A1 Method for monitoring stability of polysaccharide-protein conjugate vaccines Pending 04-Sep-2021 0000000000 EP-...

Prime Minister Narendra Modi will be visiting Serum Institute of India in Pune on Saturday to see Covid-19 vaccine production and proposed distribution plan, a senior official confirmed on Thursday. File photo: Prime Minister Narendra Modi.(PTI) “We have got an official confirmation about Prime Minister’s visit to Pune on November 28. The PM will visit Serum Institute which is into production of Covid vaccine,” said Pune divisional commissioner Saurabh Rao. The administration has already held multiple meetings to prepare for PM Modi’s visit to Pune. The Prime Minister, according to officials, will visit various facilities at SII’s Hadapsar campus where the Pune firm has begun the production of Covishield vaccine. Rao said, the Prime Minister will be at Serum Institute for an hour. “He will arrive at Lohegaon Airport at 12.30 on Saturday. After that, instead of going by road, the Prime Minister will travel by helicopter to the Serum Institute,” said Rao. The PM will also be travelling to Hyderabad the same day. Also read: Pune-based Serum Institute of India (SII), the world’s largest vaccine maker, has signed an agreement to manufacture the vaccine developed by the Jenner Institute of Oxford University in collaboration with British-Swedish pharma company AstraZeneca. Both, the University of Oxford and AstraZeneca, on Monday said that their coronavirus vaccine was up to 90 per cent effective in late-stage clinical trials, raising hopes for the arrival of shots in India by th...

• • • Serum Institute of India seeks DCGI's nod to manufacture Covid vaccine Sputnik V Serum Institute of India seeks DCGI’s nod to manufacture Covid vaccine Sputnik V The Pune-based firm has collaborated with the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow for developing Sputnik V at its Hadapsar facility. The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V COVID-19 vaccine for examination, test and analysis at its licensed Hadapsar facility in Pune, official sources said on Thursday. The Pune-based firm has collaborated with the Gamaleya Research Institute of Epidemiology and Microbiology, Moscow for developing Sputnik V at its Hadapsar facility. On May 18, the SII had also applied to the Review Committee on Genetic Manipulation (RCGM), Department of Biotechnology seeking clearance for the import of strains or seed lots and cell banks and for carrying out research and development, the sources said. Top News Right Now • 68 murdered in Maliana, all accused acquitted 36 years later, residents ask: So who killed our families? • In appeal, Rahul says was mistreated, sentenced to attract disqualification • Kalakshetra suspends 4 teachers, appoints independent committee to probe sexual harassment allegations Click here for more The SII has already told the government that it will be able to manufacture and supply 10 crore Covishield doses in June, while it is also ...

Serum Institute Of India Private Limited is a Private incorporated on 22 May 1984. It is classified as Non-govt company and is registered at Registrar of Companies, Pune. Its authorized share capital is Rs. 550,000,000 and its paid up capital is Rs. 48,192,528. It is inolved in Other education Serum Institute Of India Private Limited's Annual General Meeting (AGM) was last held on 26 September 2022 and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2022. Directors of Serum Institute Of India Private Limited are Sunil Gairola, Natasha Adar Poonawalla, Kedar Shashikant Gokhale, Prasad Suryakant Kulkarni, Rajeev Mhalasakant Dhere, Zavareh Soli Poonawalla, . Serum Institute Of India Private Limited's Corporate Identification Number is (CIN) U80903PN1984PTC032945 and its registration number is 32945.Its Email address is [email protected] and its registered address is 212/2 OFF SOLI POONAWALLA ROAD, HADAPSAR PUNE Pune MH 411028 IN . Current status of Serum Institute Of India Private Limited is - Active. Company Details CIN Company Name SERUM INSTITUTE OF INDIA PRIVATE LIMITED Company Status Active RoC RoC-Pune Registration Number 32945 Company Category Company limited by Shares Company Sub Category Non-govt company Class of Company Private Date of Incorporation 22 May 1984 Age of Company 39 years, 0 month, 25 days Activity Other education Number of Members - Financial Report Balance Sheet Paid-up Capital Reserves & S...